Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten H Ecke

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Anticancer Research|April 9, 2005
Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutationThorsten H Ecke, Horst H Schlechte, Guntram Schulze, et al.
Urologic Oncology|March 28, 2008
Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancerThorsten H Ecke, Horst H Schlechte, Sven Gunia, et al.
Journal of Medical Case Reports|January 21, 2011
Idiopathic giant abdominal lymph cyst: a case reportThorsten H Ecke, Holger Gerullis, Christoph J Heuck, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2017
UBC<sup>®</sup> Rapid Test for detection of carcinoma in situ for bladder cancerThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
International Journal of Molecular Sciences|June 3, 2018
Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the BladderAnja Rabien, Nadine Ratert, Anica Högner, et al.
International Journal of Molecular Medicine|April 22, 2008
TP53 gene mutations as an independent marker for urinary bladder cancer progressionThorsten H Ecke, Markus D Sachs, Severin V Lenk, et al.
Anticancer Research|August 5, 2010
Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?Thorsten H Ecke, Holger Gerullis, Christoph J Heuck, et al.
International Journal of Molecular Sciences|December 6, 2018
UBC<sup>®</sup> <i>Rapid</i> Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-StudyThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
International Journal of Medical Sciences|May 30, 2017
Presentation of a method at the Exploration Stage according to IDEAL: Percutaneous nephrolithotomy (PCNL) under local infiltrative anesthesia is a feasible and effective method - retrospective analysis of 439 patientsThorsten H Ecke, Dimitri Barski, Guido Weingart, et al.
Anticancer Research|May 13, 2015
Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder CancerThorsten H Ecke, Christian Arndt, Carsten Stephan, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Anticancer Research|April 9, 2005
Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutationThorsten H Ecke, Horst H Schlechte, Guntram Schulze, et al.
Urologic Oncology|March 28, 2008
Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancerThorsten H Ecke, Horst H Schlechte, Sven Gunia, et al.
Journal of Medical Case Reports|January 21, 2011
Idiopathic giant abdominal lymph cyst: a case reportThorsten H Ecke, Holger Gerullis, Christoph J Heuck, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2017
UBC<sup>®</sup> Rapid Test for detection of carcinoma in situ for bladder cancerThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
International Journal of Molecular Sciences|June 3, 2018
Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the BladderAnja Rabien, Nadine Ratert, Anica Högner, et al.
International Journal of Molecular Medicine|April 22, 2008
TP53 gene mutations as an independent marker for urinary bladder cancer progressionThorsten H Ecke, Markus D Sachs, Severin V Lenk, et al.
Anticancer Research|August 5, 2010
Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?Thorsten H Ecke, Holger Gerullis, Christoph J Heuck, et al.
International Journal of Molecular Sciences|December 6, 2018
UBC<sup>®</sup> <i>Rapid</i> Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-StudyThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
International Journal of Medical Sciences|May 30, 2017
Presentation of a method at the Exploration Stage according to IDEAL: Percutaneous nephrolithotomy (PCNL) under local infiltrative anesthesia is a feasible and effective method - retrospective analysis of 439 patientsThorsten H Ecke, Dimitri Barski, Guido Weingart, et al.
Anticancer Research|May 13, 2015
Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder CancerThorsten H Ecke, Christian Arndt, Carsten Stephan, et al.
Pageof 7